Takeda Pharmaceuticals U.S.A., Inc.

MA · United States · Reporting entity ID 100000000337

Total reported 2019–2025

$1.45B

#14 of 2,960 reporting companies — 1.7% of all reported industry payments

$621.9M in general payments across 1,090,120 records, plus $830.3M in research funding across 101,869 records.

How it breaks down

General payments $621,870,746

Research funding $830,260,405

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.